Completed PHASE2/PHASE3 INTERVENTIONAL 2-arm NCT04879030

Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD (COPD)

Is Combination Antibiotic Therapy Superior to Monotherapy in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Sponsor: Haiphong University of Medicine and Pharmacy

Conditions COPD Exacerbation Acute

Interventions Beta-Lactams Fluoroquinolone

Updated 4 times since 2021 Last updated: May 4, 2021 Started: Jan 1, 2020 Primary completion: Aug 30, 2020 Completion: Dec 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on COPD Exacerbation Acute, this trial is completed. The trial is conducted by Haiphong University of Medicine and Pharmacy and has accumulated 4 data snapshots since 2020. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2/PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2/PHASE3

Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jun 2021 — Jul 2024 [monthly]

Completed PHASE2_PHASE3

First recorded

Jan 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Haiphong University of Medicine and Pharmacy

Data source: Haiphong University of Medicine and Pharmacy

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Haiphong, Vietnam